ESPERANTE.COM KEYWORD DENSITY CHECKER

Total words: 1335 | 2-word phrases: 346 | 3-word phrases: 378 | 4-word phrases: 385

PAGE INFO

Title Try to keep the title under 60 characters (63 characters)
Esperante | Specialising in innovative life science investments
Description Try to keep the meta description between 50 - 160 characters (159 characters)
A corporate venture investment company focussed on investing in mid to late stage clinical stage therapeutics development companies in North America and Europe
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (15 characters)
About Esperante

ONE WORD PHRASES 226 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1the156.64%
2and125.31%
3of125.31%
4in125.31%
5esperante114.87%
6contact93.98%
7a73.10%
8medicenna73.10%
9therapeutics73.10%
10portfolio52.21%

TWO WORD PHRASES 346 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1contact details41.16%
2in the41.16%
3details esperante41.16%
4the development30.87%
5our portfolio30.87%
6registered in30.87%
7registration number30.87%
8quick contact30.87%
9esperante is20.58%
10on the20.58%
11infectious disease20.58%
12by a20.58%
13focused on20.58%
14at the20.58%
15company focused20.58%
16immunotherapy company20.58%
17meeting of20.58%
18of the20.58%
19the netherlands20.58%
20esperante ab20.58%

THREE WORD PHRASES 378 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1contact details esperante41.06%
2quick contact details30.79%
3corp “medicenna” or the20.53%
4on the development20.53%
5portfolio news contact20.53%
6focused on the20.53%
7company focused on20.53%
8team approach our20.53%
9about team approach20.53%
10home about team20.53%
11read full post20.53%
12immunotherapy company focused20.53%
13or the “company”20.53%
14of superkines today20.53%
15meeting of the20.53%
16of the society20.53%
17the society for20.53%
18“company” tsx mdna20.53%
19the “company” tsx20.53%
20november 2023 medicenna20.53%
21clinicalstage immunotherapy company10.26%
22a clinicalstage immunotherapy10.26%
23mdnaf a clinicalstage10.26%
24tsx mdna otc10.26%
25the development of10.26%
26development of superkines10.26%
27you have your10.26%
28superkines today announced10.26%
29singleagent response and10.26%
3012 ability study10.26%

FOUR WORD PHRASES 385 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1quick contact details esperante30.78%
2of the society for20.52%
3focused on the development20.52%
4company focused on the20.52%
5about team approach our20.52%
6home about team approach20.52%
7immunotherapy company focused on20.52%
8or the “company” tsx20.52%
9the “company” tsx mdna20.52%
10meeting of the society20.52%
11corp “medicenna” or the “company”20.52%
12the development of superkines10.26%
13“company” tsx mdna otc10.26%
14mdnaf a clinicalstage immunotherapy10.26%
15a clinicalstage immunotherapy company10.26%
16clinicalstage immunotherapy company focused10.26%
17therapeutics corp “medicenna” or the10.26%
18november 2023 medicenna therapeutics10.26%
1917 november 2023 medicenna10.26%
20neurooncology 17 november 202310.26%
21on the development of10.26%
22of superkines today announced10.26%
23development of superkines today10.26%
24post medicenna announces promising10.26%
25in the phase 1210.26%
26mdna11 in the phase10.26%
27of mdna11 in the10.26%
28durability of mdna11 in10.26%
29promising singleagent response and10.26%
30announces promising singleagent response10.26%
31medicenna announces promising singleagent10.26%
32full post medicenna announces10.26%
33society for neurooncology 1710.26%
34read full post medicenna10.26%
35medicenna read full post10.26%
36a poster presentation medicenna10.26%
37that a poster presentation10.26%
38announced that a poster10.26%
39today announced that a10.26%
40superkines today announced that10.26%

EXTERNAL LINKS

# URL Whois Check
1https://www.linkedin.com/company/esperante/about/ Whoislinkedin.com
2 https://www.topleftdesign.com Whoistopleftdesign.com